Clinical trial research agenda on COVID-19 – the first two years in Germany and beyond

BACKGROUND: We have followed the COVID-19 clinical trial research agenda from the beginning using the COVID-evidence.org platform. Now, two years after the COVID-19 pandemic started, our aim was to re-examine this research agenda with the latest data to provide a global perspective on the research l...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirt, Julian, Janiaud, Perrine, Hemkens, Lars G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier GmbH. 2022
Materias:
Evidenz in der Gesundheitsversorgung / Evidence in Health Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514972/
https://www.ncbi.nlm.nih.gov/pubmed/36180342
http://dx.doi.org/10.1016/j.zefq.2022.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514972/
https://www.ncbi.nlm.nih.gov/pubmed/36180342
http://dx.doi.org/10.1016/j.zefq.2022.08.003

Ejemplares similares